Patient Derived Xenograft (PDX) Models Market Size to Reach USD 653 Million by 2032
Global Patient Derived Xenograft (PDX) Models market is witnessing strong momentum as precision oncology and personalized medicine reshape cancer drug development worldwide. Valued at USD 358 million in 2024, the market is projected to reach USD 653 million by 2032, expanding at a robust CAGR of 9.2% during the forecast period. Increasing demand for highly predictive preclinical models, coupled with rising oncology R&D investment, continues to position PDX models as a cornerstone of modern translational cancer research.
Access the market report
https://www.24lifesciences.com/patient-derived-xenograft-pdx-models-market-9495Patient Derived Xenograft (PDX) Models Market Size to Reach USD 653 Million by 2032
Global Patient Derived Xenograft (PDX) Models market is witnessing strong momentum as precision oncology and personalized medicine reshape cancer drug development worldwide. Valued at USD 358 million in 2024, the market is projected to reach USD 653 million by 2032, expanding at a robust CAGR of 9.2% during the forecast period. Increasing demand for highly predictive preclinical models, coupled with rising oncology R&D investment, continues to position PDX models as a cornerstone of modern translational cancer research.
Access the market report https://www.24lifesciences.com/patient-derived-xenograft-pdx-models-market-9495
